Results 11 to 20 of about 8,720 (195)

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC−MS/MS [PDF]

Journal of Pharmaceutical Analysis, 2015
A simple, rapid and sensitive ultra performance liquid chromatography-tandem mass spectrometry (UPLC−MS/MS) method has been developed for the simultaneous determination of cilostazol and its pharmacologically active metabolite 3,4-dehydro cilostazol in
Nejal M. Bhatt, Vijay D. Chavada, Daxesh P. Patel, Primal Sharma, Mallika Sanyal, Pranav S. Shrivastav   +5 more
doaj   +2 more sources

Cilostazol for intermittent claudication [PDF]

Cochrane Database of Systematic Reviews, 2014
Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication (exercise-induced lower limb pain relieved by rest). These patients have a three- to six-fold increase in cardiovascular mortality.
Brown, Tamara, Forster, Rachel B, Cleanthis, Marcus, Mikhailidis, Dimitri P, Stansby, Gerard, Stewart, Marlene   +5 more
openaire   +8 more sources

Cilostazol for Probable Swallow Syncope Associated With Sick Sinus Syndrome in a Nonagenarian Receiving Home‐Based Care: A Case Report [PDF]

Journal of General and Family Medicine, Volume 27, Issue 4, July 2026.
ABSTRACT Background Swallow syncope is a rare reflex syncope, typically treated with pacemaker implantation. Pharmacological alternatives may be considered when pacemaker implantation is not feasible or not concordant with goals of care. Case Presentation We report a nonagenarian woman with dementia, very severe aortic stenosis, heart failure, and sick
Hiromitsu Yamashita, Sandeep Shakya, Masayoshi Shiota   +2 more
wiley   +2 more sources

Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylate

Drug Design, Development and Therapy, 2015
Jae Hong Seo, Jung Bae Park, Woong-Kee Choi, Sunhwa Park, Yun Jin Sung, Euichaul Oh, Soo Kyung Bae College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea Objective ...
Seo JH, Park JB, Choi WK, Park S, Sung YJ, Oh E, Bae SK   +6 more
doaj   +1 more source

Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis. [PDF]

PLoS ONE, 2015
Cilostazol has been reported to alleviate the metabolic syndrome induced by increased intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels, which is also associated with osteoclast (OC) differentiation. We hypothesized that bone loss might be
Ke Ke, Ali Muhammad Safder, Ok-Joo Sul, Jae-Hee Suh, Yeonsoo Joe, Hun-Taeg Chung, Hye-Seon Choi   +6 more
doaj   +2 more sources

Post‐Endoscopic Retrograde Cholangiopancreatography Bleeding After Endoscopic Stone Removal in Dialysis Patients: A Multicenter Retrospective Study [PDF]

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives Post‐endoscopic retrograde cholangiopancreatography (post‐ERCP) bleeding occurs more frequently in dialysis patients than in non‐dialysis patients. This study aimed to identify risk factors for post‐ERCP bleeding following stone removal in patients undergoing dialysis.
Masaki Nishimura, Haruo Miwa, Takashi Kaneko, Kazuki Endo, Ritsuko Oishi, Yuichi Suzuki, Hiromi Tsuchiya, Yoshimasa Suzuki, Yoshihiro Goda, Akihiro Funaoka, Nobutaka Doba, Kuniyasu Irie, Yuki Miura, Tomohiro Ishii, Masaaki Kondo, Kazuya Sugimori, Shin Maeda   +16 more
wiley   +2 more sources

Haemorrhagic risk of transperineal ultrasound‐guided prostate biopsy performed under continued antithrombotic therapy [PDF]

BJUI Compass, Volume 7, Issue 8, August 2026.
Abstract Objectives This study aims to evaluate the safety of transperineal prostate biopsy performed with continued antiplatelet and anticoagulant therapies under caudal anaesthesia. Patients and Methods A total of 620 consecutive patients who underwent transperineal ultrasound‐guided prostate biopsy at a tertiary care centre in Japan from March 2023 ...
Naoki Akagi, Tatsuki Kinoshita, Motoki Fujita, Riki Obayashi, Akihiro Yamamoto, Akihiko Nagoshi, Tasuku Fujiwara, Takanari Kambe, Ryo Yamamoto, Atsushi Igarashi, Yuto Hattori, Noboru Shibasaki, Mutsushi Kawakita, Toshinari Yamasaki   +13 more
wiley   +2 more sources

Impact of Cilostazol versus Cilostazol and Selenium Combination on The Healing of Diabetic Foot Ulcer Patients: A Randomized Controlled Trial [PDF]

Diabetol Metab Syndr
Background Diabetic foot ulcer (DFU) is a debilitating complication of diabetes mellitus (DM). This study aimed to compare the impact of cilostazol alone or with selenium on wound healing in non-ischemic DFU patients.
Rana Sayed, Hadeer Eid Eliwa, Lamia M. El Wakeel, Amr A. Mahfouz   +3 more
core   +2 more sources

Nano-Cilostazol Mitigates Cisplatin-Induced Nephrotoxicity in Rats via Modulation of Oxidative Stress, Apoptosis, Pyroptosis, and miRNA-155 Signaling [PDF]

Antioxidants
Background: This study investigated the renoprotective potential of Nano-Cilostazol against cisplatin (CIS)-induced renal injury in male rats and explored its molecular mechanisms.
Hebatallah M. Saad, Enas I. El Zahaby, Alyaa R. Salama, Ahmed M. Elgazzar, Hisham A. Nematalla, Mona Elharoun, Nihal E. Amer, Aml E. Hashem, Omnya Elhussieny, Ahmed Elsawasany, Salman A. A. Mohammed   +10 more
doaj   +2 more sources

Cilostazol for intermittent claudication

, 2021
Copyright \ua9 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Background: Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years.
Forster RB, Mikhailidis DP, Cleanthis M, Stewart M, Brown T, Stansby G   +5 more
core   +4 more sources